163 related articles for article (PubMed ID: 11152532)
21. Vascular endothelial growth factor: possible role in fetal development and placental function.
Cheung CY
J Soc Gynecol Investig; 1997; 4(4):169-77. PubMed ID: 9292845
[TBL] [Abstract][Full Text] [Related]
22. Na+/H+ exchanger type 1 is a receptor for pathogenic subgroup J avian leukosis virus.
Chai N; Bates P
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5531-6. PubMed ID: 16567631
[TBL] [Abstract][Full Text] [Related]
23. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
24. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor (VEGF) and its receptors.
Neufeld G; Cohen T; Gengrinovitch S; Poltorak Z
FASEB J; 1999 Jan; 13(1):9-22. PubMed ID: 9872925
[TBL] [Abstract][Full Text] [Related]
26. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
Ferrara N; Carver-Moore K; Chen H; Dowd M; Lu L; O'Shea KS; Powell-Braxton L; Hillan KJ; Moore MW
Nature; 1996 Apr; 380(6573):439-42. PubMed ID: 8602242
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
29. Two functionally distinct forms of a retroviral receptor explain the nonreciprocal receptor interference among subgroups B, D, and E avian leukosis viruses.
Adkins HB; Blacklow SC; Young JA
J Virol; 2001 Apr; 75(8):3520-6. PubMed ID: 11264341
[TBL] [Abstract][Full Text] [Related]
30. Knock-Out of Retrovirus Receptor Gene
Koslová A; Trefil P; Mucksová J; Krchlíková V; Plachý J; Krijt J; Reinišová M; Kučerová D; Geryk J; Kalina J; Šenigl F; Elleder D; Kožich V; Hejnar J
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960774
[TBL] [Abstract][Full Text] [Related]
31. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration.
Rissanen TT; Vajanto I; Hiltunen MO; Rutanen J; Kettunen MI; Niemi M; Leppänen P; Turunen MP; Markkanen JE; Arve K; Alhava E; Kauppinen RA; Ylä-Herttuala S
Am J Pathol; 2002 Apr; 160(4):1393-403. PubMed ID: 11943724
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
Tian X; Song S; Wu J; Meng L; Dong Z; Shou C
Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087
[TBL] [Abstract][Full Text] [Related]
33. A genetically engineered cell line resistant to subgroup J avian leukosis virus infection (C/J).
Hunt HD; Lee LF; Foster D; Silva RF; Fadly AM
Virology; 1999 Nov; 264(1):205-10. PubMed ID: 10544146
[TBL] [Abstract][Full Text] [Related]
34. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
[TBL] [Abstract][Full Text] [Related]
35. A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors.
Federspiel MJ; Bates P; Young JA; Varmus HE; Hughes SH
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11241-5. PubMed ID: 7972042
[TBL] [Abstract][Full Text] [Related]
36. [Angiogenesis--vascular endothelial growth factor and its receptors].
Shibuya M
Hum Cell; 1999 Mar; 12(1):17-24. PubMed ID: 10457901
[TBL] [Abstract][Full Text] [Related]
37. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
Millauer B; Shawver LK; Plate KH; Risau W; Ullrich A
Nature; 1994 Feb; 367(6463):576-9. PubMed ID: 8107827
[TBL] [Abstract][Full Text] [Related]
38. Functionally active VEGF fusion proteins.
Backer MV; Backer JM
Protein Expr Purif; 2001 Oct; 23(1):1-7. PubMed ID: 11570839
[TBL] [Abstract][Full Text] [Related]
39. Molecular biology of the VEGF and the VEGF receptor family.
Clauss M
Semin Thromb Hemost; 2000; 26(5):561-9. PubMed ID: 11129413
[TBL] [Abstract][Full Text] [Related]
40. [Growth factors binding heparin: FGF and VEGF. Physiological and physiopathological importance, therapeutic implications in diabetic retinopathy].
Favard C; Patry V; Prats H; Plouet J; Bayard F
Journ Annu Diabetol Hotel Dieu; 1995; ():39-51. PubMed ID: 7602891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
